Sleep-Disordered Breathing (SDB) is a complex and multifaceted medical condition that affects millions of people worldwide. It encompasses a range of disorders, including snoring, Obstructive Sleep Apnea (OSA) and Central Sleep Apnea (CSA), all of which disrupt the normal breathing patterns during sleep. Despite its prevalence and potential health consequences, sleep-disordered breathing remains a puzzling enigma in the medical field. This article aims to shed light on the mechanisms, clinical consequences and treatment strategies associated with this intriguing condition. The clinical impact of SDB and explores emerging treatment approaches that offer innovative solutions to mitigate its consequences. The recurrent episodes of disrupted breathing lead to fragmented sleep, daytime sleepiness and cognitive impairment. The cumulative effect of sleep deprivation can significantly impact quality of life, mood and productivity. Moreover, SDB has been associated with an increased risk of cardiovascular diseases, including hypertension, arrhythmias, stroke and heart failure. Addressing the clinical impact of SDB is crucial for improving patients quality of life and reducing the burden on healthcare systems.
HTML PDFShare this article
